While our results clearly demonstrate that Keap1 hypomorphism in mice leads to Nrf2 overexpression and mitigation of experimental BPD, the exact mechanisms through which targeting Keap1 confers protection is unclear. Here, NFE2L2 is linked to bronchopulmonary dysplasia.